These metabolite-epitranscriptome interactions remodel immunogenic RNA landscapes, deplete nutrients essential for tumor-infiltrating lymphocytes, and stabilize PD-L1 transcripts, collectively reinforcing an immune-evasive niche. The gene discussed is CD274; the disease is neoplasm.